Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study

Mechanisms of ischaemia-induced arrhythmias in hypertrophic cardiomyopathy: a large-scale computational study

<p><strong>Aims:</strong> Lethal arrhythmias in hypertrophic cardiomyopathy (HCM) are widely attributed to myocardial ischaemia and fibrosis. How these factors modulate arrhythmic risk remains largely unknown, especially as invasive mapping protocols are not routinely used in these...

ver descrição completa

Detalhes bibliográficos
Principais autores:	Coleman, JA, Doste, R, Ashkir, Z, Coppini, R, Sachetto, R, Watkins, H, Raman, B, Bueno Orovio, A
Formato:	Journal article
Idioma:	English
Publicado em:	Oxford University Press 2024

Registros relacionados

Mechanisms and prognostic impact of myocardial ischaemia in hypertrophic cardiomyopathy
por: Coleman, JA, et al.
Publicado em: (2023)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: Coleman, JA, et al.
Publicado em: (2024)

Remodelling of potassium currents underlies arrhythmic action potential prolongation under beta-adrenergic stimulation in hypertrophic cardiomyopathy
por: Doste, R, et al.
Publicado em: (2022)

Effects of ranolazine on the arrhythmic substrate in hypertrophic cardiomyopathy
por: James A. Coleman, et al.
Publicado em: (2024-04-01)

Electrophysiological mechanisms underlying T wave pseudonormalisation on stress ECGs in hypertrophic cardiomyopathy
por: Coleman, J, et al.
Publicado em: (2023)

Pharmacological management of hypertrophic cardiomyopathy: From bench to bedside
por: Palandri, C, et al.
Publicado em: (2022)

Identification of myocardial disarray in patients with hypertrophic cardiomyopathy and ventricular arrhythmias
por: Ariga, R, et al.
Publicado em: (2019)

Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy
por: Coleman, JA
Publicado em: (2024)

Mechanisms of pro-arrhythmic abnormalities in ventricular repolarisation and anti-arrhythmic therapies in human hypertrophic cardiomyopathy.
por: Passini, E, et al.
Publicado em: (2015)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Margara, F, et al.
Publicado em: (2022)

Adenosine stress T1 mapping: a novel contrast free method to assess myocardial perfusion and ischaemia in hypertrophic cardiomyopathy
por: Raman, B, et al.
Publicado em: (2017)

Non-invasive imaging of myocardial disarray associates with ventricular arrhythmia in hypertrophic cardiomyopathy
por: Ariga, R, et al.
Publicado em: (2017)

Arrhythmia Monitoring for Risk Stratification in Hypertrophic Cardiomyopathy
por: Darson Du, MD, et al.
Publicado em: (2022-04-01)

Radiofrequency catheter ablation of ventricular arrhythmias in patients with hypertrophic cardiomyopathy
por: Muthiah Subramanian, et al.
Publicado em: (2024-01-01)

Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
por: Francesca Margara, et al.
Publicado em: (2022-12-01)

Files associated with: "Investigations of electrophysiological mechanisms related to myocardial ischaemia in hypertrophic cardiomyopathy: implications for arrhythmic risk, ECG diagnosis, and antiarrhythmic therapy"
por: Coleman, J
Publicado em: (2024)

A multi-scale computational investigation of cardiac electrophysiology and arrhythmias in acute ischaemia
por: Dutta, S
Publicado em: (2014)

Sudden death in hypertrophic cardiomyopathy.
por: Watkins, H
Publicado em: (2000)

Ventricular arrhythmias in apical hypertrophic cardiomyopathy: association with late gadolinium enhancement
por: Lopes Mário G, et al.
Publicado em: (2010-01-01)

International Practice Patterns in the Detection and Management of Arrhythmias in Patients With Hypertrophic Cardiomyopathy
por: Matthew Cheung, et al.
Publicado em: (2022-10-01)

Ventricular Arrhythmias in Hypertrophic Cardiomyopathy- Can We Ever Predict Them?
por: Narayanan Namboodiri, et al.
Publicado em: (2010-03-01)

Ventricular Arrhythmia in Septal and Apical Hypertrophic Cardiomyopathy: The French-Canadian Experience
por: Christian Steinberg, et al.
Publicado em: (2020-10-01)

Myocardial dysfunction in hypertrophic cardiomyopathy.
por: Ashrafian, H, et al.
Publicado em: (2001)

Improving the clinical understanding of hypertrophic cardiomyopathy by combining patient data, machine learning and computer simulations: A case study
por: Lyon, A, et al.
Publicado em: (2019)

Ventricular arrhythmia and sudden cardiac death in hypertrophic cardiomyopathy: From bench to bedside
por: Hua Shen, et al.
Publicado em: (2022-08-01)

Burden and trends of arrhythmias in hypertrophic cardiomyopathy and its impact of mortality and resource utilization
por: Byomesh Tripathi, et al.
Publicado em: (2019-08-01)

Multiscale modelling of β-adrenergic stimulation in cardiac electromechanical function
por: Doste, R, et al.
Publicado em: (2021)

Electrocardiogram phenotypes in hypertrophic cardiomyopathy caused by distinct mechanisms: apico-basal repolarization gradients vs. Purkinje-myocardial coupling abnormalities
por: Lyon, A, et al.
Publicado em: (2018)

Metabolic perturbations in the pathogenesis of hypertrophic cardiomyopathy
por: Ashrafian, H, et al.
Publicado em: (2005)

Novel insights into diminished cardiac reserve in non-obstructive hypertrophic cardiomyopathy from four-dimensional flow cardiac magnetic resonance component analysis
por: Ashkir, Z, et al.
Publicado em: (2023)

Hypertrophic cardiomyopathy in Noonan Syndrome closely mimics familial hypertrophic cardiomyopathy due to sarcomeric mutations.
por: Hudsmith, L, et al.
Publicado em: (2006)

Electrophysiological and Contractile Effects of Disopyramide in Patients With Obstructive Hypertrophic Cardiomyopathy: a Translational Study
por: Coppini, R, et al.
Publicado em: (2019)

INFLUENCE OF THE POLYMORPHISM OF THE RENIN-ANGIOTENSIN SYSTEM GENES ON THE CARDIAC ARRHYTHMIAS IN CHILDREN WITH HYPERTROPHIC CARDIOMYOPATHY
por: N. A. Berezneva, et al.
Publicado em: (2013-05-01)

High‐Resolution ECG for Predicting Ventricular Arrhythmia in Hypertrophic Cardiomyopathy: Another Tool in the Toolbox
por: Anil K. Gehi
Publicado em: (2022-12-01)

The genetics of hypertrophic cardiomyopathy: Teare redux.
por: Watkins, H, et al.
Publicado em: (2008)

HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
por: A. G. Osiev, et al.
Publicado em: (2016-02-01)

Diffusion tensor magnetic resonance imaging of myocardial disarray in hypertrophic cardiomyopathy
por: Ariga, R, et al.
Publicado em: (2018)

Is DNA testing for hypertrophic cardiomyopathy cost-effective?
por: Wordsworth, S, et al.
Publicado em: (2006)

Genetic clues to disease pathways in hypertrophic and dilated cardiomyopathies.
por: Watkins, H
Publicado em: (2003)

Linked genetic modifiers in hypertrophic cardiomyopathy
por: Ektisham, J, et al.
Publicado em: (2004)